These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 25538755)

  • 1. X-ray repair cross-complementing gene 1 Arg399Gln polymorphism and glioma risk among Asians: A meta-analysis based on 2 326 cases and 3 610 controls.
    Zhang L; Qiu Z; Luo J; Shu W
    Neural Regen Res; 2012 Oct; 7(29):2313-9. PubMed ID: 25538755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between the XRCC1 polymorphisms and glioma risk: a meta-analysis of case-control studies.
    Jiang L; Fang X; Bao Y; Zhou JY; Shen XY; Ding MH; Chen Y; Hu GH; Lu YC
    PLoS One; 2013; 8(1):e55597. PubMed ID: 23383237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between X-ray cross-complementing group 1 polymorphisms and the onset risk of glioma: A meta-analysis.
    Gu X; Sun H; Chang L; Sun R; Yang H; Zhang X; Cong X
    Neural Regen Res; 2013 Sep; 8(26):2468-77. PubMed ID: 25206557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. XRCC1 Arg399Gln variation and leukemia susceptibility: evidence from 2,647 cases and 5,518 controls.
    Huang Y; Xie D; Tang N; Wang J; Zeng X; Zhao P; He L
    Tumour Biol; 2014 Jan; 35(1):799-808. PubMed ID: 23990457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. X-ray repair cross-complementing group 1 Arg399Gln gene polymorphism and susceptibility to colorectal cancer:a meta-analysis.
    Zeng FR; Ling Y; Yang J; Tian XC; Yang X; Luo RC
    Tumour Biol; 2013 Feb; 34(1):555-63. PubMed ID: 23188703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Association Between the XRCC1 Arg399Gln Polymorphism and the Risk of Head and Neck Cancer: An Updated Meta-Analysis Including 14586 Subjects.
    Xia S; Wu S; Wang M
    Technol Cancer Res Treat; 2021; 20():15330338211033060. PubMed ID: 34278875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. XRCC1 Arg399Gln genetic polymorphism and the risk of hepatocellular carcinoma: a meta-analysis.
    Qi Y; Cui L; Song Y; Li N
    Mol Biol Rep; 2014 Feb; 41(2):879-87. PubMed ID: 24390232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphisms of DNA repair gene XRCC1 and hepatocellular carcinoma risk among East Asians: a meta-analysis.
    Li J; Li Z; Feng L; Guo W; Zhang S
    Tumour Biol; 2013 Feb; 34(1):261-9. PubMed ID: 23055199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. XRCC1 genetic polymorphism Arg399Gln and hepatocellular carcinoma risk: a meta-analysis.
    Liu F; Li B; Wei Y; Yan L; Wen T; Zhao J; Xu M
    Liver Int; 2011 Jul; 31(6):802-9. PubMed ID: 21645210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of X-ray repair cross complementing group 1 Arg399Gln polymorphisms with the risk of squamous cell carcinoma of the head and neck: evidence from an updated meta-analysis.
    Wang Y; Chu X; Meng X; Zou F
    PLoS One; 2013; 8(10):e77898. PubMed ID: 24205020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A functional polymorphism in XRCC1 is associated with glioma risk: evidence from a meta-analysis.
    Wei X; Chen D; Lv T
    Mol Biol Rep; 2013 Jan; 40(1):567-72. PubMed ID: 23096083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meta-analysis demonstrates no association between XRCC1 Arg399Gln polymorphism and bladder cancer risk.
    Dong LM; Zhang XY; Teng H; Li MS; Wang P
    Genet Mol Res; 2014 Nov; 13(4):9976-85. PubMed ID: 25501209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of XRCC1 Arg399Gln and Arg194Trp polymorphisms with susceptibility to multiple autoimmune diseases: a meta-analysis.
    Peng M; Zhou X; Ding X; Wei L; Zhao Y; Zhu T; Shi X; Qin D
    Rheumatol Int; 2017 Mar; 37(3):435-444. PubMed ID: 27812739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between X-ray repair cross-complementing group 1(XRCC1) Arg399Gln polymorphism and endometriosis: A systematic review and meta-analysis.
    Lv MQ; Wang J; Yu XQ; Hong HH; Ren WJ; Ge P; Zhou DX
    Eur J Obstet Gynecol Reprod Biol; 2017 Nov; 218():12-20. PubMed ID: 28926725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. XRCC1 gene polymorphisms and glioma risk in Chinese population: a meta-analysis.
    He LW; Shi R; Jiang L; Zeng Y; Ma WL; Zhou JY
    PLoS One; 2014; 9(11):e111981. PubMed ID: 25375625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. XRCC1 Arg399Gln polymorphism and bladder cancer risk: updated meta-analyses based on 5767 cases and 6919 controls.
    Zhuo W; Zhang L; Cai L; Zhu B; Chen Z
    Exp Biol Med (Maywood); 2013 Jan; 238(1):66-76. PubMed ID: 23479765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. X-ray repair cross-complementing group 1 polymorphisms and hepatocellular carcinoma: a meta-analysis.
    Xie T; Wang ZG; Zhang JL; Liu H
    World J Gastroenterol; 2012 Aug; 18(31):4207-14. PubMed ID: 22919255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Updated assessment of the association of the XRCC1 Arg399Gln polymorphism with lung cancer risk in the Chinese population.
    Yang HY; Yang SY; Shao FY; Wang HY; Wang YD
    Asian Pac J Cancer Prev; 2015; 16(2):495-500. PubMed ID: 25684477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of the association between XRCC1 Arg399Gln polymorphism and glioma susceptibility.
    Zhu W; Yao J; Li Y; Xu B
    Tumour Biol; 2014 Apr; 35(4):3061-6. PubMed ID: 24258108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between polymorphisms in DNA repair gene
    Wang L; Xu J; Duan B
    Onco Targets Ther; 2017; 10():3475-3483. PubMed ID: 28761356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.